Dunhill Financial’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$149 Buy
90
+89
+8,900% +$5.21K ﹤0.01% 1366
2026
Q2
$63 Hold
1
– – ﹤0.01% 1478
2026
Q1
$35 Sell
1
-1
-50% -$20 ﹤0.01% 1685
2025
Q4
$27 Buy
+2
New +$30 ﹤0.01% 1850

Other funds holding TXG

Dunhill Financial's TXG Position: Q3 2026 in Review

Dunhill Financial increased its 10x Genomics (TXG) stake by 8,900% in Q3 2026, buying an estimated $5.21K and bringing the position to 90 shares worth $149. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Dunhill Financial first reported a position in TXG in Q4 2025 and has held it in 4 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Dunhill Financial held 90 shares of 10x Genomics worth $149 as of Q3 2026.
  • Dunhill Financial bought 89 10x Genomics shares in Q3 2026, an estimated $5.21K.
  • 10x Genomics made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1366 holding.
  • Dunhill Financial first reported a position in 10x Genomics in Q4 2025 and has held it in 4 quarters since.
  • 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.